Longitudinal Study of Insomnia Symptoms Among Women During Perimenopause

Colleen Ciano, Tonya King, Robin Redmon Wright, Michael Perlis, Amy M. Sawyer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective To describe the prevalence of insomnia symptoms among women during perimenopause and to examine differences in self-reported insomnia symptoms at different stages of perimenopause over 10 years. Design Secondary analysis of self-reported sleep symptoms and clinical variables using 10 years of publicly available data from the Study of Women Across the Nation (SWAN). Setting The data set of women's insomnia symptoms was obtained from publicly available data from the SWAN. The parent study settings included Detroit, Michigan; Northern New Jersey; Los Angeles, California; Boston, Massachusetts; Chicago, Illinois; and Pittsburgh, Pennsylvania. Participants Multiethnic midlife women with a mean age of 46 years (N = 3,302) categorized as pre- and perimenopausal at baseline. Methods Dependent variables included self-reported insomnia symptoms: difficulty falling asleep (sleep latency), wake after sleep onset, early morning awakenings, and sleep quality. Descriptive analysis was completed for each 1-year study interval. Repeated measures logistic regression was used to identify whether insomnia symptoms changed over time by stage of perimenopause. Results Insomnia symptoms were present in 31% to 42% of perimenopausal women at any 1-year study interval. Insomnia symptoms were more prevalent in the late stage of perimenopause than the early stage (p <.001). The odds of having any insomnia symptoms were 1.3 times greater for women in the late stage of perimenopause than in the early stage (95% confidence interval [1.2, 1.5], p <.001). Conclusion Insomnia symptoms are prevalent in women transitioning to menopause, and stage of perimenopause may heighten the risk to develop symptoms of insomnia disorder, which is associated with negative cardiometabolic outcomes.

Original languageEnglish (US)
Pages (from-to)804-813
Number of pages10
JournalJOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing
Volume46
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Perimenopause
Sleep Initiation and Maintenance Disorders
Longitudinal Studies
Sleep
Los Angeles
Menopause

All Science Journal Classification (ASJC) codes

  • Pediatrics
  • Critical Care
  • Maternity and Midwifery

Cite this

@article{f0eae8280e4647a384fdf02f9102d16a,
title = "Longitudinal Study of Insomnia Symptoms Among Women During Perimenopause",
abstract = "Objective To describe the prevalence of insomnia symptoms among women during perimenopause and to examine differences in self-reported insomnia symptoms at different stages of perimenopause over 10 years. Design Secondary analysis of self-reported sleep symptoms and clinical variables using 10 years of publicly available data from the Study of Women Across the Nation (SWAN). Setting The data set of women's insomnia symptoms was obtained from publicly available data from the SWAN. The parent study settings included Detroit, Michigan; Northern New Jersey; Los Angeles, California; Boston, Massachusetts; Chicago, Illinois; and Pittsburgh, Pennsylvania. Participants Multiethnic midlife women with a mean age of 46 years (N = 3,302) categorized as pre- and perimenopausal at baseline. Methods Dependent variables included self-reported insomnia symptoms: difficulty falling asleep (sleep latency), wake after sleep onset, early morning awakenings, and sleep quality. Descriptive analysis was completed for each 1-year study interval. Repeated measures logistic regression was used to identify whether insomnia symptoms changed over time by stage of perimenopause. Results Insomnia symptoms were present in 31{\%} to 42{\%} of perimenopausal women at any 1-year study interval. Insomnia symptoms were more prevalent in the late stage of perimenopause than the early stage (p <.001). The odds of having any insomnia symptoms were 1.3 times greater for women in the late stage of perimenopause than in the early stage (95{\%} confidence interval [1.2, 1.5], p <.001). Conclusion Insomnia symptoms are prevalent in women transitioning to menopause, and stage of perimenopause may heighten the risk to develop symptoms of insomnia disorder, which is associated with negative cardiometabolic outcomes.",
author = "Colleen Ciano and Tonya King and Wright, {Robin Redmon} and Michael Perlis and Sawyer, {Amy M.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.jogn.2017.07.011",
language = "English (US)",
volume = "46",
pages = "804--813",
journal = "JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing",
issn = "0884-2175",
publisher = "Wiley-Blackwell",
number = "6",

}

Longitudinal Study of Insomnia Symptoms Among Women During Perimenopause. / Ciano, Colleen; King, Tonya; Wright, Robin Redmon; Perlis, Michael; Sawyer, Amy M.

In: JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing, Vol. 46, No. 6, 01.11.2017, p. 804-813.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Longitudinal Study of Insomnia Symptoms Among Women During Perimenopause

AU - Ciano, Colleen

AU - King, Tonya

AU - Wright, Robin Redmon

AU - Perlis, Michael

AU - Sawyer, Amy M.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Objective To describe the prevalence of insomnia symptoms among women during perimenopause and to examine differences in self-reported insomnia symptoms at different stages of perimenopause over 10 years. Design Secondary analysis of self-reported sleep symptoms and clinical variables using 10 years of publicly available data from the Study of Women Across the Nation (SWAN). Setting The data set of women's insomnia symptoms was obtained from publicly available data from the SWAN. The parent study settings included Detroit, Michigan; Northern New Jersey; Los Angeles, California; Boston, Massachusetts; Chicago, Illinois; and Pittsburgh, Pennsylvania. Participants Multiethnic midlife women with a mean age of 46 years (N = 3,302) categorized as pre- and perimenopausal at baseline. Methods Dependent variables included self-reported insomnia symptoms: difficulty falling asleep (sleep latency), wake after sleep onset, early morning awakenings, and sleep quality. Descriptive analysis was completed for each 1-year study interval. Repeated measures logistic regression was used to identify whether insomnia symptoms changed over time by stage of perimenopause. Results Insomnia symptoms were present in 31% to 42% of perimenopausal women at any 1-year study interval. Insomnia symptoms were more prevalent in the late stage of perimenopause than the early stage (p <.001). The odds of having any insomnia symptoms were 1.3 times greater for women in the late stage of perimenopause than in the early stage (95% confidence interval [1.2, 1.5], p <.001). Conclusion Insomnia symptoms are prevalent in women transitioning to menopause, and stage of perimenopause may heighten the risk to develop symptoms of insomnia disorder, which is associated with negative cardiometabolic outcomes.

AB - Objective To describe the prevalence of insomnia symptoms among women during perimenopause and to examine differences in self-reported insomnia symptoms at different stages of perimenopause over 10 years. Design Secondary analysis of self-reported sleep symptoms and clinical variables using 10 years of publicly available data from the Study of Women Across the Nation (SWAN). Setting The data set of women's insomnia symptoms was obtained from publicly available data from the SWAN. The parent study settings included Detroit, Michigan; Northern New Jersey; Los Angeles, California; Boston, Massachusetts; Chicago, Illinois; and Pittsburgh, Pennsylvania. Participants Multiethnic midlife women with a mean age of 46 years (N = 3,302) categorized as pre- and perimenopausal at baseline. Methods Dependent variables included self-reported insomnia symptoms: difficulty falling asleep (sleep latency), wake after sleep onset, early morning awakenings, and sleep quality. Descriptive analysis was completed for each 1-year study interval. Repeated measures logistic regression was used to identify whether insomnia symptoms changed over time by stage of perimenopause. Results Insomnia symptoms were present in 31% to 42% of perimenopausal women at any 1-year study interval. Insomnia symptoms were more prevalent in the late stage of perimenopause than the early stage (p <.001). The odds of having any insomnia symptoms were 1.3 times greater for women in the late stage of perimenopause than in the early stage (95% confidence interval [1.2, 1.5], p <.001). Conclusion Insomnia symptoms are prevalent in women transitioning to menopause, and stage of perimenopause may heighten the risk to develop symptoms of insomnia disorder, which is associated with negative cardiometabolic outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85033384372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033384372&partnerID=8YFLogxK

U2 - 10.1016/j.jogn.2017.07.011

DO - 10.1016/j.jogn.2017.07.011

M3 - Article

VL - 46

SP - 804

EP - 813

JO - JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

JF - JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

SN - 0884-2175

IS - 6

ER -